US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
GT Biopharma Inc (GTBP)
GT Biopharma Inc (GTBP) ニュース

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GTBP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/18	05 : 26	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
2024/06/14	05 : 14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
2024/06/08	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2024/05/24	09 : 31	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
2024/05/23	19 : 04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:GTBP	GT Biopharma Inc
2024/05/23	19 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2024/05/16	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2024/02/15	04 : 46	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GTBP	GT Biopharma Inc
2024/02/02	02 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/12/22	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/12/05	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07 : 25	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07 : 23	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:GTBP	GT Biopharma Inc
2023/11/07	07 : 21	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:GTBP	GT Biopharma Inc
2023/11/01	22 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2023/10/28	06 : 23	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:GTBP	GT Biopharma Inc
2023/09/20	00 : 56	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GTBP	GT Biopharma Inc
2023/08/23	05 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/08/16	08 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
2023/08/16	08 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTBP	GT Biopharma Inc
2023/08/07	22 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GTBP	GT Biopharma Inc
2023/07/05	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTBP	GT Biopharma Inc
2023/05/06	06 : 30	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/06	06 : 29	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/05	08 : 15	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GTBP	GT Biopharma Inc
2023/05/04	22 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc
2023/04/12	08 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GTBP	GT Biopharma Inc
2023/03/31	06 : 02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GTBP	GT Biopharma Inc
2023/02/15	02 : 55	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GTBP	GT Biopharma Inc
2023/01/04	20 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GTBP	GT Biopharma Inc

Showing the most relevant articles for your search:NASDAQ:GTBP

1 2 3 4 次へ >>

Energy Select Sector SPDR

Gold vs US Dollar

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約